All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology
Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial
(BJU International)
16 october 2019 23:04:30
Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial
(BJU International)
Tweet
BJU International, Volume 0, Issue ja, -Not available-.
191 views
Category:
Urology
Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
(BMC Urology)
PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study
(BMC Urology)
Please enable JavaScript to view the
comments powered by Disqus.
blog comments powered by
Disqus
MyJournals.org
The latest issues of all your favorite science journals on one page
Username:
Password:
Register
|
Retrieve
Search:
Google:
Copyright © 2008 - 2024
Indigonet Services B.V.
. Contact:
Tim Hulsen
. Read
here
our privacy notice.
Other websites of Indigonet Services B.V.:
Nieuws
Vacatures
News
Tweets
Nachrichten